Option (4) task order - SAF 25- 4001 quantiferon-TB gold plus
Ended Awarded Last action
- Contract number
- W81K0224F0106
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $84,947
Award facts
- Opportunity
-
- Automated ID serology analyzer Pre-Solicitation · W81K0220Q0128 · Posted May 12, 2020
- Contract value 100% obligated
- $84,947.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Germantown, MD, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $84,947 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a $84,947 delivery order to Qiagen, LLC for QuantiFERON-TB Gold Plus testing reagents and related consumables under an existing indefinite delivery contract. This task order, designated SAF 25-4001, represents Option 4 funding additions for fiscal year 2025 and will be performed at Qiagen's Germantown, Maryland facility. The contract utilizes firm fixed-price pricing with no small business set-aside and is scheduled for completion by September 30, 2025. This delivery order is issued under Qiagen's larger $489,895 Indefinite Delivery Contract with the Defense Health Agency, which extends through September 2030 and supports military medical readiness and occupational health screening programs.
Qiagen, a foreign-owned molecular diagnostics manufacturer headquartered in Germantown, Maryland, is a preferred supplier to multiple federal agencies including the Defense Health Agency, Veterans Integrated Service Networks, National Institutes of Health, Centers for Disease Control and Prevention, and the Federal Bureau of Investigation. The company specializes in providing DNA/RNA extraction kits, tuberculosis testing reagents, bioinformatics software, and next-generation sequencing equipment. The QuantiFERON-TB Gold Plus assays supplied under this order support occupational health monitoring and tuberculosis screening across the military healthcare system, aligning with the Defense Health Agency's mission to ensure medical readiness and preventative health programs for Department of Defense beneficiaries.
Quick answers
Who was awarded contract W81K0224F0106?
W81K0224F0106 was awarded to Qiagen, LLC by Medical Command (Department of the Army) on October 1, 2024.
How much is contract W81K0224F0106 worth?
The government has obligated $84,947 on W81K0224F0106.
Which agency awarded contract W81K0224F0106?
Medical Command (Department of the Army) awarded W81K0224F0106, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0224F0106 an order under another contract?
Yes. W81K0224F0106 is a delivery order under W81K0220D0020, an indefinite delivery contract.
Was contract W81K0224F0106 competed?
The extent of competition for W81K0224F0106 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award